NewsEconomic development

Bio Logbook in Quebec

Bio Logbook took part in its second Mission Collective to Quebec, organized by Nantes Métropole. This mission, which took place from May 28 to 31, 2024, brought together a delegation of economic players from Nantes, and enabled Bio Logbook to develop its presence on the Canadian market and forge promising new partnerships.

Fruitful meetings with key players in healthcare and AI

During this mission, Bio Logbook had the honor of meeting key players in the healthcare and AI fields in Quebec, including researchers, clinicians, entrepreneurs and representatives of public institutions. These meetings were an opportunity for the company to present its innovative solutions in biological data analysis and artificial intelligence, and aroused keen interest among participants.

Enriching exchanges on health issues

The meetings organized as part of the Mission Collective also enabled Bio Logbook to compare the challenges faced by healthcare players in Quebec and France, particularly in terms of medical data management and the use of artificial intelligence. These enriching exchanges enabled the company to better understand the needs and challenges of the Quebec market, and to adapt its approach accordingly.

A strong commitment to research and innovation

Bio Logbook was particularly moved by the commitment and passion of the researchers and professionals it met in Quebec. The company shares this commitment and reaffirms its ambition to help improve patient health through innovative solutions based on artificial intelligence.

Live from Bio Logbook.

Find out about our latest news, collaborations and study projects.

NewsCollaborationStudyTrophies
June 26. 2024

NephroGuard has been selected as one of the Unirein Third-Party experimentation projects.

Bio Logbook's NephroGuard project joins forces with Unirein to optimize management Read more
NewsCollaborationStudyPublication
June 7. 2024

Bio Logbook reaches a major milestone with the publication of a ground-breaking study in the journal CCA Clinica Chimica Acta.

It is with great pride that Bio Logbook announces the publication of its first study Read more
NewsEconomic development
Apr. 10, 2024

Bio Logbook joins the French Healthcare BOOSTER GERMANY.

Bio Logbook has been selected to participate in the French Healthcare BOOSTER GERMANY 2024 program .
NewsEconomic development

Bio Logbook joins the French Healthcare BOOSTER GERMANY.

Bio Logbook has been selected to take part in the French Healthcare BOOSTER GERMANY 2024, an acceleration program dedicated to French healthcare companies looking to expand in Germany.

This selection recognizes our expertise in digital solutions for clinical trial management and our strong growth potential in the German market.

A new stage in Bio Logbook's international expansion

A customized support program

The French Healthcare BOOSTER GERMANY 2024 will enable us to benefit from 9 months of tailor-made support. During this program, we will have access to :

  • Individual support from coaches and experts in the German market.
  • Training courses and workshops to better understand the German market and the specificities of its healthcare system.
  • Connections with potential partners, such as investors, customers and institutional players.

A springboard for international business

We are convinced that the French Healthcare BOOSTER GERMANY 2024 will be a valuable springboard for our development in Germany. This program will enable us to :

  • Accelerate our international growth.
  • Strengthen our presence in the German market, one of the largest in Europe.
  • Identify new partnership and collaboration opportunities.

We're proud to be part of this adventure alongside other innovative companies in the healthcare sector.

Together, we'll be helping to promote French know-how in Germany and improve patient health.

Find out more about the program and the winners

Live from Bio Logbook.

Find out about our latest news, collaborations and study projects.

NewsCollaborationStudyTrophies
June 26. 2024

NephroGuard has been selected as one of the Unirein Third-Party experimentation projects.

Bio Logbook's NephroGuard project joins forces with Unirein to optimize management Read more
NewsCollaborationStudyPublication
June 7. 2024

Bio Logbook reaches a major milestone with the publication of a ground-breaking study in the journal CCA Clinica Chimica Acta.

It is with great pride that Bio Logbook announces the publication of its first study Read more
NewsEconomic development
June 3. 2024

Bio Logbook in Quebec

Bio Logbook took part in its second Mission Collective in Quebec, organized by Nantes Métropole. Read more
NewsEconomic development

Bio Logbook has been selected by the Pays de la Loire Region as part of the international gas pedal dedicated to innovative healthcare.

Bio Logbook accelerates its international development with the support of the Pays de la Loire Region.

A new milestone in healthcare innovation

We are proud to announce that Bio Logbook has been selected by the Pays de la Loire Region as part of its international gas pedal program dedicated to innovative healthcare. This selection represents a major recognition of our expertise in digital solutions for clinical trial management, and of our strong growth potential on international markets.

Tailor-made support for a successful internationalization strategy

For 18 months, we'll be receiving tailor-made support from TEAM FRANCE EXPORT PAYS DE LA LOIRE, ALTIOS International and Katalyse, all recognized experts in international business support.

This support program will enable us to :

  • Access specific financing and assistance to support our international growth.
  • Define and refine our international development strategy by identifying the most promising markets and adapting our offering to the specific needs of each country.
  • Benefit from a network of experts and partners to facilitate our international expansion and forge strategic partnerships.

Live from Bio Logbook.

Find out about our latest news, collaborations and study projects.

NewsCollaborationStudyTrophies
June 26. 2024

NephroGuard has been selected as one of the Unirein Third-Party experimentation projects.

Bio Logbook's NephroGuard project joins forces with Unirein to optimize management Read more
NewsCollaborationStudyPublication
June 7. 2024

Bio Logbook reaches a major milestone with the publication of a ground-breaking study in the journal CCA Clinica Chimica Acta.

It is with great pride that Bio Logbook announces the publication of its first study Read more
NewsEconomic development
June 3. 2024

Bio Logbook in Quebec

Bio Logbook took part in its second Mission Collective in Quebec, organized by Nantes Métropole. Read more